Altaviz

Altaviz

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Founded in 2012, Altaviz is a private medical device design and development firm that creates innovative drug delivery and ophthalmic solutions. Its business model is centered on providing engineering services and leveraging proprietary technology frameworks, such as gas-powered injectors and implant delivery systems, to accelerate client product development. The company is revenue-generating, partnering with industry leaders to bring next-generation delivery devices to market, with a team boasting a strong track record in patents and commercial product launches. Its core expertise lies in translating complex delivery challenges into effective, manufacturable devices that improve patient care and clinical workflow.

Ophthalmology

Technology Platform

Proprietary, modular frameworks for drug and implant delivery, including Implant Delivery, Fluid Injector, Auto-Injector, and Gas Injector systems. The gas-powered technology platform uses medical-grade compressed gas as a precision energy source for next-generation delivery devices.

Opportunities

The growing demand for sustained-release drug delivery, particularly in ophthalmology for conditions like AMD, presents a major opportunity.
Additionally, the trend towards self-administration and the need for precise, reliable delivery systems for biologics across therapeutic areas expands their potential client base.
Their innovative gas-powered platform could capture a niche in high-precision delivery applications.

Risk Factors

Revenue is dependent on the flow of client projects from the biopharma sector, creating client concentration and cyclical risk.
The competitive landscape for device design services is intense, requiring constant innovation.
The company's success is also indirectly tied to the clinical success of its partners' drug candidates.

Competitive Landscape

Altaviz competes with other medical device design and development firms (e.g., SMC Ltd., Phillips-Medisize, Nemera) and in-house R&D teams at large pharma/device companies. Its differentiation lies in its specialized focus on delivery frameworks, deep ophthalmic expertise, and its proprietary gas-powered technology platform, which offers a distinct alternative to traditional power sources.